Skip to main content
Log in

Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure

  • Research Paper
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract

Anemia is a common complication of autonomic failure and reduced red blood cell mass may contribute to the orthostatic hypotension of these patients. We investigated whether treatment with recombinant erythropoietin improves anemia and increases blood pressure in patients with primary autonomic failure. Three patients with multiple system atrophy and autonomic failure and one with pure autonomic failure were studied. All patients had normocytic normochromic anemia and low (n = 2) or normal (n = 2) serum levels of erythropoietin. Treatment with erythropoietin, 4000 U subcutaneously biweekly for 6 weeks, increased hematocrit and blood pressure in all patients. Hematocrit increased from 33.9 ± 0.7 to 44.3 ± 1.4%, blood pressure in supine position increased from 150 ± 8/87 ± 8 (systolic/diastolic; mean ± SD) to 166 ± 25/92 ± 12 mmHg, and after 3 min in the head-up tilt position from 86 ± 21/47 ± 15 to 102 ± 23/63 ± 12 mmHg, (p < 0.05). All patients reported improvement in orthostatic symptoms and increased tolerance to standing. The study shows that treatment with erythropoietin improves anemia, increases blood pressure and ameliorates orthostatic hypotension in patients with primary autonomic failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kaufmann H, Oribe E, Pierotti ARet al. Atrial natriuretic factor in human autonomic failure.Neurology 1990;40: 1115–1119.

    Article  CAS  PubMed  Google Scholar 

  2. Biaggioni I, Robertson D, Krantz Set al. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin.Ann Intern Med 1994;121: 181–186.

    Article  CAS  PubMed  Google Scholar 

  3. Goldberg MA, Dunning SP, Bunn HF. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein.Science 1988;242: 1412–1415.

    Article  CAS  PubMed  Google Scholar 

  4. Maxwell AP, Lappin TR, Bridges JM, McGeown MC. Erythropoietin production in kidney tubular cells.Br J Haematol 1990;74: 535–539.

    Article  CAS  PubMed  Google Scholar 

  5. McGonigle RJ, Wallin JD, Shadduck RK. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency.Kidney Int 1984;25: 437–444.

    Article  CAS  PubMed  Google Scholar 

  6. Kaufmann H, Brannan T, Krakoff Let al. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha adrenergic agonist (Midodrine).Neurology 1988;38: 951–956.

    Article  CAS  PubMed  Google Scholar 

  7. Hoeldtke RD, Streeten DHP. Treatment of orthostatic hypotension with erythropoietin.N Engl J Med 1993;329: 611–615.

    Article  CAS  PubMed  Google Scholar 

  8. Anand P, Cotes PM, Rudge P. Anaemia with inappropriately low erythropoietin in a new autonomic and sensory neuropathy attributed to nerve growth factor deficiency.Clin Sci 1991;80: 16P.

  9. Raine AE, Roger SD. Effects of erythropoietin on blood pressure.Am J Kidney Dis 1991;18 (suppl 1): 76–83.

    CAS  PubMed  Google Scholar 

  10. Anagnostou A, Lee ES, Kessimian Net al. Erythropoietin has mitogenic and positive chemotactic effect on endothelial cells.Proc Natl Acad Sci 1990;87: 5978–5982.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Carlini R, Obialo CI, Rothstein M. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.Am J Hypertens 1993;6: 103–107.

    CAS  PubMed  Google Scholar 

  12. Takahashi K, Totsune K, Imai Yet al. Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin.Clin Sci 1993;84: 47–50.

    Article  CAS  PubMed  Google Scholar 

  13. Martin W, Smith JA, White DG. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor.Br J Pharmacol 1986;89: 563–571.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Nushiro N, Sakamaki T, Misawa Set al. The effects of intrarenal infusion of recombinant human erythropoietin on renal hemodynamics and renal function in anesthetized rabbits.Nippon Jinzo Gakkai Shi 1993;35(2): 125–131.

    CAS  PubMed  Google Scholar 

  15. Neusser M, Tepel M, Zidek W. Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells.Cardiovasc Res 1993;27(7): 1233–1236.

    Article  CAS  PubMed  Google Scholar 

  16. Perera R, Isola L, Kaufmann H. Erythropoietin improves orthostatic hypotension in primary autonomic failure.Neurology 1994;44 (suppl. 2): A363.

    Google Scholar 

  17. Mirand EA, Murphy GP, Bennett TB, Grace JT. Erythropoietin response to repeated hemorrhage in renal allotransplanted, nephrectomized, or intact dogs.Life Sci 1968;7: 689–696.

    Article  CAS  Google Scholar 

  18. Eckardt K-U, Frei U, Kliem Vet al. Role of excretory graft function for erythropoietin formation after renal transplantation.Eur J Clin Invest 1990;20: 564–574.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perera, R., Isola, L. & Kaufmann, H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clinical Autonomic Research 5, 211–213 (1995). https://doi.org/10.1007/BF01824009

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01824009

Keywords

Navigation